HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
43 hedge funds and large institutions have $21.3M invested in Hepion Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
Holders
43
Holding in Top 10
–
Calls
$1.42M
Puts
$1.38M
Top Buyers
| 1 | +$2.7M | |
| 2 | +$1.48M | |
| 3 | +$883K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$639K |
| 5 |
Two Sigma Investments
New York
|
+$485K |
Top Sellers
| 1 | -$564K | |
| 2 | -$296K | |
| 3 | -$290K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$246K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$230K |